Interaction between paracetamol and coumarin anticoagulants

Avoidance of "first-pass" elimination of rectally administered propranolol in relation to the site of absorption in rats.

Pharmaceutical research·2013

Site specific rectal drug administration in man with an osmotic system: influence on "first-pass" elimination of lidocaine.

Pharmaceutical research·2013

Correlation between in vivo antipyrine metabolite formation and theophylline metabolism in rats.

Pharmaceutical research·2013

P-glycoprotein inhibition leads to enhanced disruptive effects by anti-microtubule cytostatics at the in vitro blood-brain barrier.

Pharmaceutical research·2001

Active efflux of the 5-HT(1A) receptor agonist flesinoxan via P-glycoprotein at the blood-brain barrier.

European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences·2001

Glucocorticoid and type 1 interferon interactions at the blood-brain barrier: relevance for drug therapies for multiple sclerosis.

Neuroreport·2001

Multivessel coronary artery bypass grafting via small thoracotomy versus sternotomy (MIST): an investigator-initiated, international, open-label, randomised controlled trial.

Lancet (London, England)·2026

Efficacy and safety of once-weekly subcutaneous zenagamtide, a novel unimolecular GLP-1 and amylin receptor agonist, in type 2 diabetes: a multicentre, randomised, parallel, double-blind, placebo-controlled, dose-finding, phase 2 trial.

Lancet (London, England)·2026

Efficacy and safety of once-daily oral zenagamtide, a novel unimolecular GLP-1 and amylin receptor agonist, in adults with type 2 diabetes: a multicentre, randomised, parallel, double-blind, placebo-controlled, dose-finding, phase 2 trial.

Lancet (London, England)·2026

Senkyunolide I Inhibits mtDNA-cGAS-STING Signaling in Macrophages via Targeting VDAC1 Oligomerization to Attenuate Ulcerative Colitis.

Advanced science (Weinheim, Baden-Wurttemberg, Germany)·2026

Vitamin B3 (Nicotinamide) Supplementation in Primary and Scleroderma-Related Raynaud Phenomenon.

ACR open rheumatology·2026

An injectable self-healing curcumin-sustained-release hydrogel for lower limb ischemia via autophagy inhibition by Atp6v0d2 downregulation.

Regenerative biomaterials·2026

Cannabis-Based Oil for Pain and Other Non-Motor Symptoms in Parkinson's Disease: A Randomized Controlled Trial.

Movement disorders : official journal of the Movement Disorder Society·2026

Smart Responsive Hydrogels for Dry Eye Disease: Microenvironment-Sensing Drug Delivery and Therapeutic Translation.

Journal of ocular pharmacology and therapeutics : the official journal of the Association for Ocular Pharmacology and Therapeutics·2026

Antihyperalgesic effects of ACE2 activation in a neuropathic pain model involve spinal MAS1 receptor signaling and ATP-sensitive potassium channels.

Biochemical pharmacology·2026

Related Experiment Videos

Interaction between paracetamol and coumarin anticoagulants

Related Concept Videos

Avoidance of "first-pass" elimination of rectally administered propranolol in relation to the site of absorption in rats.

Site specific rectal drug administration in man with an osmotic system: influence on "first-pass" elimination of lidocaine.

Correlation between in vivo antipyrine metabolite formation and theophylline metabolism in rats.

P-glycoprotein inhibition leads to enhanced disruptive effects by anti-microtubule cytostatics at the in vitro blood-brain barrier.

Active efflux of the 5-HT(1A) receptor agonist flesinoxan via P-glycoprotein at the blood-brain barrier.

Glucocorticoid and type 1 interferon interactions at the blood-brain barrier: relevance for drug therapies for multiple sclerosis.

Multivessel coronary artery bypass grafting via small thoracotomy versus sternotomy (MIST): an investigator-initiated, international, open-label, randomised controlled trial.

Efficacy and safety of once-weekly subcutaneous zenagamtide, a novel unimolecular GLP-1 and amylin receptor agonist, in type 2 diabetes: a multicentre, randomised, parallel, double-blind, placebo-controlled, dose-finding, phase 2 trial.

Efficacy and safety of once-daily oral zenagamtide, a novel unimolecular GLP-1 and amylin receptor agonist, in adults with type 2 diabetes: a multicentre, randomised, parallel, double-blind, placebo-controlled, dose-finding, phase 2 trial.

Senkyunolide I Inhibits mtDNA-cGAS-STING Signaling in Macrophages via Targeting VDAC1 Oligomerization to Attenuate Ulcerative Colitis.

Vitamin B3 (Nicotinamide) Supplementation in Primary and Scleroderma-Related Raynaud Phenomenon.

An injectable self-healing curcumin-sustained-release hydrogel for lower limb ischemia via autophagy inhibition by Atp6v0d2 downregulation.

Cannabis-Based Oil for Pain and Other Non-Motor Symptoms in Parkinson's Disease: A Randomized Controlled Trial.

Smart Responsive Hydrogels for Dry Eye Disease: Microenvironment-Sensing Drug Delivery and Therapeutic Translation.

Antihyperalgesic effects of ACE2 activation in a neuropathic pain model involve spinal MAS1 receptor signaling and ATP-sensitive potassium channels.

Related Experiment Videos

Interaction between paracetamol and coumarin anticoagulants

Related Concept Videos

Related Articles